# Jan Novák

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/jan-novak/

## Facts

| Field | Value |
| --- | --- |
| Citations | 22,390 |
| Field | Renal Diseases and Glomerulopathies |
| h-index | 82 |
| i10-index | 186 |
| Last Known Institution | University of Alabama at Birmingham |
| OpenAlex ID | https://openalex.org/A5031087263 |
| ORCID iD | https://orcid.org/0000-0002-9211-6670 |
| Works | 335 |

## Researcher papers

Showing 12 of 19.

- [The Pathophysiology of IgA Nephropathy](https://scholariq.org/papers/the-pathophysiology-of-iga-nephropathy/)
- [Discovery of new risk loci for IgA nephropathy implicates genes involved in immunity against intestinal pathogens](https://scholariq.org/papers/discovery-of-new-risk-loci-for-iga-nephropathy-implicates-genes-involved-in/)
- [Genome-wide association study identifies susceptibility loci for IgA nephropathy](https://scholariq.org/papers/genome-wide-association-study-identifies-susceptibility-loci-for-iga-nephropathy/)
- [Naturally Occurring Human Urinary Peptides for Use in Diagnosis of Chronic Kidney Disease](https://scholariq.org/papers/naturally-occurring-human-urinary-peptides-for-use-in-diagnosis-of-chronic/)
- [IgA nephropathy](https://scholariq.org/papers/iga-nephropathy-2/)
- [Aberrantly glycosylated IgA1 in IgA nephropathy patients is recognized by IgG antibodies with restricted heterogeneity](https://scholariq.org/papers/aberrantly-glycosylated-iga1-in-iga-nephropathy-patients-is-recognized-by-igg/)
- [Geographic Differences in Genetic Susceptibility to IgA Nephropathy: GWAS Replication Study and Geospatial Risk Analysis](https://scholariq.org/papers/geographic-differences-in-genetic-susceptibility-to-iga-nephropathy-gwas/)
- [Current Understanding of the Role of Complement in IgA Nephropathy](https://scholariq.org/papers/current-understanding-of-the-role-of-complement-in-iga-nephropathy/)
- [Clinical proteomics: A need to define the field and to begin to set adequate standards](https://scholariq.org/papers/clinical-proteomics-a-need-to-define-the-field-and-to-begin-to-set-adequate/)
- [A Randomized, Controlled Trial of Rituximab in IgA Nephropathy with Proteinuria and Renal Dysfunction](https://scholariq.org/papers/a-randomized-controlled-trial-of-rituximab-in-iga-nephropathy-with-proteinuria/)
- [Urinary Proteomics in Diabetes and CKD](https://scholariq.org/papers/urinary-proteomics-in-diabetes-and-ckd/)
- [IgA1-secreting cell lines from patients with IgA nephropathy produce aberrantly glycosylated IgA1](https://scholariq.org/papers/iga1-secreting-cell-lines-from-patients-with-iga-nephropathy-produce-aberrantly/)

## Researcher topics

- [Renal Diseases and Glomerulopathies](https://scholariq.org/topics/renal-diseases-and-glomerulopathies/)
- [Glycosylation and Glycoproteins Research](https://scholariq.org/topics/glycosylation-and-glycoproteins-research/)
- [Monoclonal and Polyclonal Antibodies Research](https://scholariq.org/topics/monoclonal-and-polyclonal-antibodies-research/)
- [Platelet Disorders and Treatments](https://scholariq.org/topics/platelet-disorders-and-treatments/)
- [Chronic Kidney Disease and Diabetes](https://scholariq.org/topics/chronic-kidney-disease-and-diabetes/)

## Researcher university

- [University of Alabama at Birmingham](https://scholariq.org/institutions/university-of-alabama-at-birmingham/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.